Cargando…

Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial

BACKGROUND: Network analysis has been used to explore the interplay between psychopathology and functioning in psychosis, but no study has used dedicated statistical techniques to focus on the bridge symptoms connecting these domains. The current study aims to estimate the network of depressive, neg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Santo, Francesco, Fonseca-Pedrero, Eduardo, García-Portilla, María Paz, González-Blanco, Leticia, Sáiz, Pilar A., Galderisi, Silvana, Giordano, Giulia Maria, Bobes, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251819/ https://www.ncbi.nlm.nih.gov/pubmed/35686446 http://dx.doi.org/10.1192/j.eurpsy.2022.25

Ejemplares similares

Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the OPTiMiSE trial
por: Dal Santo, F., et al.
Publicado: (2023)

Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)
por: Pandit, R., et al.
Publicado: (2019)

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies
por: Worker, Amanda, et al.
Publicado: (2023)

Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study
por: Demjaha, Arsime, et al.
Publicado: (2023)

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial
por: Susai, Subash Raj, et al.
Publicado: (2023)

A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
por: ter Hark, Sophie E, et al.
Publicado: (2020)

Medication adherence in first-episode psychosis and its association with psychopathology
por: Raghavan, Vijaya, et al.
Publicado: (2019)

Self-Awareness of Psychopathology and Brain Volume in Patients With First Episode Psychosis
por: Kim, Jeong-Youn, et al.
Publicado: (2019)

Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients
por: Waszczuk, Katarzyna, et al.
Publicado: (2022)

Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
por: Melillo, Antonio, et al.
Publicado: (2023)

Psychiatry residency during the COVID-19 pandemic: Navigating uncharted waters
por: Dal Santo, Francesco, et al.
Publicado: (2020)

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2019)

Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders
por: González-Blanco, Leticia, et al.
Publicado: (2023)

Psychopathological networks in psychosis and changes over time: A long-term cohort study of first-episode psychosis
por: Gil-Berrozpe, G., et al.
Publicado: (2022)

Effectiveness of social skills training conducted in a group of subjects with first-episode psychosis
por: Brando, F., et al.
Publicado: (2021)

OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
por: Sheppard, James P, et al.
Publicado: (2018)

Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
por: García-Portilla, María Paz, et al.
Publicado: (2021)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
por: Rek-Owodziń, Katarzyna, et al.
Publicado: (2022)

O11.2. CHANGES IN PSYCHOPATHOLOGY PREDICT CHANGES IN WORKING ALLIANCE IN FIRST EPISODE PSYCHOSIS
por: Melau, Marianne, et al.
Publicado: (2018)

F12. INFLAMMATORY BIOMARKERS AND COGNITION IN FIRST EPISODE PSYCHOSIS: GENDER DIFFERENCES
por: Llorca, Bibiana Cabrera, et al.
Publicado: (2018)

Quality of life in schizophrenic patients
por: Bobes, Julio, et al.
Publicado: (2007)

31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS
por: Dazzan, Paola, et al.
Publicado: (2018)

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment
por: Steiner, Johann, et al.
Publicado: (2020)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

SOD and CAT as potential preliminary biomarkers for the differential diagnosis of schizophrenia and bipolar disorder in the first episode of psychosis
por: Cachán-Vega, C., et al.
Publicado: (2023)

COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?
por: González-Blanco, Leticia, et al.
Publicado: (2020)

O1.7. PROTEOMIC ANALYSIS OF BLOOD BASED SAMPLES FROM THE OPTiMiSE (OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE) STUDY POINT TOWARDS COMPLEMENT PATHWAY PROTEIN CHANGES
por: Föcking, Melanie, et al.
Publicado: (2018)

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
por: Dahl, Anne Sofie A., et al.
Publicado: (2023)

Psychopathology Related to Energy Drinks: A Psychosis Case Report
por: Hernandez-Huerta, Daniel, et al.
Publicado: (2017)

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences
por: Dal Santo, Francesco, et al.
Publicado: (2020)

Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial
por: Jowett, Sue, et al.
Publicado: (2022)

Association of serum Brain derived Neurotrophic Factor with psychopathology in First Episode Psychosis and its alteration with antipsychotics: A prospective study
por: Bharadwaj, Chayanika
Publicado: (2022)

Depressive Features in Individuals with First Episode Psychosis: Psychopathological and Treatment Considerations from A 2-Year Follow-Up Study
por: Pelizza, Lorenzo, et al.
Publicado: (2023)

Beyond the Transnosographic Emphasis on Psychosis: Nosological Perspectives on Schizophrenia and Its Prevention
por: Comparelli, Anna, et al.
Publicado: (2019)

Stereotype Awareness, Self-Esteem and Psychopathology in People with Psychosis
por: van Zelst, Catherine, et al.
Publicado: (2014)

Psychopathology and treatment responsiveness of patients with first-episode schizophrenia
por: Češková, Eva, et al.
Publicado: (2005)

Violence in first-episode psychosis: evidence from an early intervention in psychosis programme
por: Mentxaka, Oihane, et al.
Publicado: (2023)

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
por: Hidalgo-Figueroa, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bu36sdg67kmv78s8m6095pg2c7